SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-006615
Filing Date
2019-02-01
Accepted
2019-02-01 19:21:32
Documents
2
Period of Report
2019-01-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1606
2 POA DOCUMENT poa.txt EX-24.3_829589 4230
  Complete submission text file 0001209191-19-006615.txt   7144
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Issuer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080
Business Address
SULIMAN SHEHNAAZ (Reporting) CIK: 0001713070 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36276 | Film No.: 19561315